Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
[Feature articles] “Pioneer technologies of the extracelluar vesicle-based drug discovery and diagnosis” Editor:Hidetaka Akita
Development of immunotherapy using extracellular vesicles
Yuki TakahashiYoshinobu Takakura
Author information
JOURNAL FREE ACCESS

2021 Volume 36 Issue 2 Pages 100-107

Details
Abstract
Extracellular vesicles (EVs) exert producing cell-derived functions so that development of EV-based therapeutics is expected. There are a variety of immunotherapies using EVs. Main ones are vaccine therapy to induce antigen-specific immune response and anti-inflammatory therapy using EVs isolated from mesenchymal stem cells and other immunomodulatory cells. In recent years, results suggesting the possibility of immunotherapy utilizing EVs as vesicles secreted by cells and other characteristics unique to EVs have also been reported. In this article, we will introduce the current status of immunotherapy using EVs and discuss the future possibilities of EV-based immunotherapy.
Content from these authors
© 2021 The Japan Society of Drug Delivery System
Previous article Next article
feedback
Top